Rosuvastatin Calcium

component of oligomeric golgi complex 2 ; Homo sapiens







101 Article(s)
Download
PMID
Title
Pub. Year
#Total Relationships
51 19838098 Rosuvastatin versus pravastatin in dyslipidemic HIV-1-infected patients receiving protease inhibitors: a randomized trial. 2010 Jan 2 3
52 20130569 ABCG2 polymorphism is associated with the low-density lipoprotein cholesterol response to rosuvastatin. 2010 May 3
53 20195400 Comparative study of low doses of rosuvastatin and atorvastatin on lipid and glycemic control in patients with metabolic syndrome and hypercholesterolemia. 2010 Mar 1
54 20335146 [Effects of rosuvastatin on left ventricular cardiac function, arteriosclerotic plaque and high sensitive C-reactive protein in hypertensive patients with mild LDL-C elevation]. 2010 Mar 3
55 20679960 Pharmacogenetic analysis of lipid responses to rosuvastatin in Chinese patients. 2010 Oct 1
56 20953684 Efficacy and safety of rosuvastatin 5 mg in combination with fenofibric acid 135 mg in patients with mixed dyslipidemia - a phase 3 study. 2010 Dec 1
57 21090830 The cost effectiveness of statin therapies in Spain in 2010, after the introduction of generics and reference prices. 2010 2
58 21090831 Rosuvastatin: a review of its use in the prevention of cardiovascular disease in apparently healthy women or men with normal LDL-C levels and elevated hsCRP levels. 2010 3
59 21122696 Switching from high-efficacy lipid-lowering therapies to simvastatin and low-density lipoprotein cholesterol goal attainment in coronary heart disease/coronary heart disease-equivalent patients. 2010 Nov-Dec 2
60 22291492 A review on the rationale and clinical use of concomitant rosuvastatin and fenofibrate/fenofibric acid therapy. 2010 1
61 18996523 Efficacy and safety of ABT-335 (fenofibric acid) in combination with rosuvastatin in patients with mixed dyslipidemia: a phase 3 study. 2009 May 2
62 19174696 Impact of a compliance program on cholesterol control: results of the randomized ORBITAL study in 8108 patients treated with rosuvastatin. 2009 Apr 1
63 19729865 Effects of rosuvastatin on low-density lipoprotein cholesterol and plasma lipids in Asian patients with hypercholesterolemia. 2009 Aug 5
64 19745745 A randomized, controlled trial of simvastatin versus rosuvastatin in patients with acute myocardial infarction: the Secondary Prevention of Acute Coronary Events--Reduction of Cholesterol to Key European Targets Trial. 2009 Dec 2
65 19916726 Effectiveness of rosuvastatin in reducing LDL-C and target LDL-C goal attainment in real-world clinical practice. 2009 Dec 8
66 19997842 [Achievement of blood lipid target levels with Ezetimibe/Simvastatin in patients with atherosclerosis and/or diabetes mellitus--an Austrian observational study]. 2009 1
67 23555375 A Randomized Controlled Study to Compare the Effects of Rosuvastatin 2.5 mg and Pravastatin 10 mg on the Plasma Lipid Profile in Japanese Patients with Hypercholesterolemia (ASTRO-1). 2009 3
68 23555376 A Randomized Controlled Study to Compare the Effects of Rosuvastatin 5 mg and Atorvastatin 10 mg on the Plasma Lipid Profile in Japanese Patients with Hypercholesterolemia (ASTRO-2). 2009 2
69 18364261 Efficacy and safety of rosuvastatin in Taiwanese patients. 2008 Mar 1
70 18434729 Efficacy and tolerability of rosuvastatin and atorvastatin when force-titrated in patients with primary hypercholesterolemia: results from the ECLIPSE study. 2008 4
71 18489494 Statin cost-effectiveness comparisons using real-world effectiveness data: formulary implications. 2008 Dec 4
72 18578957 LDL-C reductions and goal attainment among naive statin users in the Netherlands: real life results. 2008 Aug 2
73 18654867 Impact of enhanced compliance initiatives on the efficacy of rosuvastatin in reducing low density lipoprotein cholesterol levels in patients with primary hypercholesterolaemia. 2008 Jul 26 1
74 18690760 Effects of low-dose atorvastatin and rosuvastatin on plasma lipid profiles: a long-term, randomized, open-label study in patients with primary hypercholesterolemia. 2008 4
75 21291725 Effect of ezetimibe/simvastatin versus atorvastatin or rosuvastatin on modifying lipid profiles in patients with diabetes, metabolic syndrome, or neither: Results of two subgroup analyses. 2008 Apr 4
76 21291777 Ezetimibe/simvastatin compared with atorvastatin or rosuvastatin in lowering to specified levels both LDL-C and each of five other emerging risk factors for coronary heart disease: Non-HDL-cholesterol, TC/HDL-C, apolipoprotein B, apo-B/apo-A-I, or C-reactive protein. 2008 Dec 1
77 17484092 [Compared with atorvastatin at the dose of 10 mg per day rosuvastatin was more effective to reach an LDL goal of < 1.00 g/l in high cardiovascular risk patients (ARIANE study)]. 2007 Apr 3
78 17655813 Effectiveness of rosuvastatin in low-density lipoprotein cholesterol lowering and National Cholesterol Education Program Adult Treatment Panel guideline III LDL-C goal attainment compared to other statins among diabetes mellitus patients: a retrospective study using an electronic medical records dataset in the United States. 2007 Sep 7
79 17996658 Low-density lipoprotein cholesterol (LDL-C) levels and LDL-C goal attainment among elderly patients treated with rosuvastatin compared with other statins in routine clinical practice. 2007 Sep 5
80 18158079 Titration patterns with rosuvastatin as compared with other statins in clinical practice: a retrospective observational cohort study using an electronic medical record database. 2007 Nov 5
81 21291692 Further reduction of low-density lipoprotein cholesterol and C-reactive protein with the addition of ezetimibe to maximum-dose rosuvastatin in patients with severe hypercholesterolemia. 2007 Aug 2
82 16533939 Effect of very high-intensity statin therapy on regression of coronary atherosclerosis: the ASTEROID trial. 2006 Apr 5 1
83 16644314 Achieving LDL cholesterol, non-HDL cholesterol, and apolipoprotein B target levels in high-risk patients: Measuring Effective Reductions in Cholesterol Using Rosuvastatin therapY (MERCURY) II. 2006 May 3
84 17112329 Effectiveness and cost-effectiveness of rosuvastatin, atorvastatin, and simvastatin among high-risk patients in usual clinical practice. 2006 Nov 4
85 17212997 Expanding options with a wider range of rosuvastatin doses. 2006 Nov 3
86 15707472 Review of efficacy of rosuvastatin 5 mg. 2005 Jan 4
87 16128507 Rosuvastatin: a high-potency HMG-CoA reductase inhibitor. 2005 Jul-Aug 2
88 16143705 A comparative study with rosuvastatin in subjects with metabolic syndrome: results of the COMETS study. 2005 Dec 4
89 16186052 Rosuvastatin is cost-effective compared with atorvastatin in reaching cholesterol goals. 2005 Oct 10 6
90 15161326 Medical lipid-regulating therapy: current evidence, ongoing trials and future developments. 2004 2
91 15215813 Efficacy and safety of rosuvastatin and atorvastatin in patients with hypercholesterolemia and a high risk of coronary heart disease: a randomized, controlled trial. 2004 Jul 5
92 15531000 Rosuvastatin in the management of hyperlipidemia. 2004 Sep 6
93 15639694 Twelve-week, multicenter, randomized, open-label comparison of the effects of rosuvastatin 10 mg/d and atorvastatin 10 mg/d in high-risk adults: a DISCOVERY study. 2004 Nov 4
94 16035394 A review of the efficacy of rosuvastatin in patients with type 2 diabetes. 2004 Oct 3
95 19667621 New evidence supporting aggressive lipid lowering. 2003 Apr 1
96 11900720 Managing dyslipidemia in the high-risk patient. 2002 Mar 7 2
97 12137448 Statin therapy: rationale for a new agent, rosuvastatin. 2002 Jun 3
98 12238638 Clinical effects of rosuvastatin, a new HMG-CoA reductase inhibitor, in Japanese patients with primary hypercholesterolemia: an early phase II study. 2002 1
99 12486415 Management of dyslipidemia in the high-risk patient. 2002 Dec 2
100 11256849 Statin therapy and reductions in low-density lipoprotein cholesterol: initial clinical data on the potent new statin Rosuvastatin. 2001 Mar 8 2